Early burn related gram positive systemic infection in children admitted to a pediatric surgical ward

Burns : Journal of the International Society for Burn Injuries
Francis SerourEli Somekh

Abstract

Gram positive infections, including toxic shock syndrome (TSS), may be an early complication following burns, especially in children. To identify risk factors associated with early burn related gram positive systemic infection (EBGI) in children admitted to a Pediatric Surgical Ward. A retrospective analysis of the records of all EBGI patients treated from January 1995 to December 2004. EBGI patients were defined as having systemic signs of infection appearing in the first 48 h following the burn and associated with: (1) clinical signs of toxin mediated illness and/or (2) positive blood culture of either Staphylococcus aureus or group A beta hemolytic Streptococcus. Demographic and clinical data were also collected from the charts of 150 randomly selected burn patients admitted during the study period. We identified 13 cases of EBGI (2.5%) among 518 children admitted for thermal burns (mean age: 2.4 years). Three had bacteremia without rash. The 10 other patients were diagnosed as having a toxin mediated disease. S. aureus grew from the burn wound in six patients. All EBGI patients recovered following antibiotic therapy. Significant differences between the groups included: percentage of burned body surface area (6.9% versus 3.9...Continue Reading

References

Jun 1, 1975·The Journal of Trauma·J M Larkin, J A Moylan
Jun 1, 1990·Burns : Journal of the International Society for Burn Injuries·R P Cole, P G Shakespeare
Apr 1, 1988·Burns, Including Thermal Injury·A N BrainM D Eve
Apr 1, 1985·Burns, Including Thermal Injury·J D FrameA D Wilmshurst
Jan 1, 1984·Annual Review of Microbiology·P J ChesneyJ M Vergeront
Dec 1, 1994·Burns : Journal of the International Society for Burn Injuries·C ChildsP J Davenport
Feb 1, 1993·Burns : Journal of the International Society for Burn Injuries·R M McAllisterR Sanders
Aug 1, 1996·Burns : Journal of the International Society for Burn Injuries·V Edwards-JonesH A Foster
Sep 25, 1999·Burns : Journal of the International Society for Burn Injuries·C ChildsP J Davenport
Nov 24, 1999·Burns : Journal of the International Society for Burn Injuries·S J WitheyC C Walker
Apr 7, 2000·Burns : Journal of the International Society for Burn Injuries·V Edwards-JonesC Childs
Jan 4, 2001·The New England Journal of Medicine·C von EiffG Peters
Mar 20, 2002·Burns : Journal of the International Society for Burn Injuries·D Johnson, P D R Pathirana
Dec 5, 2002·Burns : Journal of the International Society for Burn Injuries·Rameshwar L BangImad Al Najjadah
Oct 15, 2003·Burns : Journal of the International Society for Burn Injuries·Alastair P BrownStephen Sinclair
Dec 25, 2003·Burns : Journal of the International Society for Burn Injuries·A O UgburoG O A Sowemimo
Mar 17, 2004·Burns : Journal of the International Society for Burn Injuries·M TropG Feierl
Aug 4, 2004·Journal of Pediatric and Adolescent Gynecology·Chris Nelson
Jan 5, 2005·European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [et Al] = Zeitschrift Für Kinderchirurgie·O ErgünG Ozok
Feb 3, 2005·Burns : Journal of the International Society for Burn Injuries·Michelle C WhiteAmber E R Young
Jan 21, 2006·International Journal of Medical Microbiology : IJMM·Roman HrstkaJirí Doskar

❮ Previous
Next ❯

Citations

Feb 15, 2011·Journal of the American Academy of Dermatology·Edgar S MaciasBijan Safai
Jun 14, 2019·Annals of Plastic Surgery·Ankur KhajuriaJoanne Atkins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.